Press release
10 December, 2009
Disclosure Notice
Jonas af Jochnick (Co-founder and board member of Oriflame) has today
sold 1,000,000 shares in Oriflame Cosmetics SA. The holding of Jonas
af Jochnick and family will thereafter amount to 4,057,217 shares,
corresponding to approximately 7.2% of the votes and capital of
Oriflame Cosmetics SA.
"I have today sold 1,000,000 shares in Oriflame to a group of
institutional investors. As co-founder, a member of the Board
of Directors of Oriflame and one of the major shareholders in the
company, I want to make the following statement:
This transaction has been carried out to strengthen the liquidity and
to facilitate the future development of companies where I am the
majority shareholder, primarily the health care company Medicover and
the private equity company Oresa Ventures. Medicover has during the
last few years invested significant amounts in acquisitions within
the laboratory sector and the construction of a large hospital in
Warsaw. During the next few years investments of a similar magnitude
is planned and the now completed sales of Oriflame shares will
support the financing of these investments.
My commitment to Oriflame will remain the same and I am not planning
any additional divestments of Oriflame shares" Jonas af Jochnick
comments.
For additional information, please contact:
Jonas af Jochnick +32 494 538 823
Oriflame Cosmetics is an international beauty company selling direct.
The company began operations in 1967 in Sweden and has today a
presence in 62 countries worldwide. Oriflame offers a wide portfolio
of Swedish, natural, innovative, quality beauty products at
affordable prices. To-date Oriflame has over 3.0 million consultants
worldwide with annual sales of ¤1.3 billion. Oriflame offers the
leading business opportunity for people who want to start making
money the same day they join and then grow into a leadership role and
fulfil their personal dreams and ambitions. Oriflame is listed on
NASDAQ OMX Stockholm since 2004.
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.